More than half of TrumpRx drugs have a cheaper alternative

Axios – Friday, February 6, 2026
By Maya Goldman

More than half of the drugs listed on the new TrumpRx website have or will soon have a cheaper generic version on the market that can be purchased through other direct-to-consumer sites.

Why it matters: Patients could save more buying nonbrand copycat drugs, even if they don’t have insurance and pay cash, drug pricing experts say.

Case in point: Pristiq, an antidepressant made by Pfizer, is available with a TrumpRx coupon for about $200 for a 30-day supply — a more than 50% discount from the list price.

But a month’s worth of a generic version with the same dosage is available on GoodRx for less than $30, and on Mark Cuban’s CostPlusDrugs for just $16.65.

Where it stands: 20 of the 43 drugs listed on TrumpRx as of the website’s launch have generic alternatives, according to a tally by Anna Kaltenboeck, a drug pricing expert and president of Verdant Research.

Another six contain components that are available as generics or compounded products, or have tentative approvals, meaning consumers will have access to the lower-cost products in the near future.

“To the extent that a patient was buying these without insurance, I don’t see this being a benefit,” Kaltenboeck said.

Context: Pharmaceutical companies get patents for new drugs that give them market exclusivity for a set period.

Once a patent expires, the drug can face competition from generics that bring prices down.

Nine out of 10 U.S. prescriptions are for generics, according to the Food and Drug Administration.

The intrigue: TrumpRx could help “funnel people to higher price-products and [take] money from them that they don’t need to be spending when there’s actually much cheaper alternatives out there,” said Sarah Karlin-Smith, research director for the Access to Medicines program at Public Citizen.

A White House spokesperson told Axios that it’s possible that cheaper alternatives are available for some products listed on TrumpRx, but said the site’s value is in providing the lowest-cost option for branded products.

The site has a disclaimer about checking copays first and is meant to give people options, not steer them in any direction, the spokesperson added.

Reality check: Consumers may have a personal preference for a branded drug over a generic.

Generic drugs are reviewed by the FDA to make sure they perform the same way and contain the same active ingredients as brand-name products.
But the FDA doesn’t generally test generic drugs for quality concerns, and has failed to test products from factories with serious safety violations in the past, according to a ProPublica investigation published in December.

Access this article at its original source.